Pets at Home Group
PETS · Main Market · Retail · mcap £910m · 211.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 05 Oct 26 | Routine | Transaction in Own Shares | |
| 01 Oct 26 | Routine | Total Voting Rights | |
| 28 Sep 26 | Routine | Transaction in Own Shares | |
| 21 Sep 26 | Routine | Transaction in Own Shares | |
| 14 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 14 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 14 Sep 26 | Routine | Transaction in Own Shares | |
| 07 Sep 26 | Routine | Transaction in Own Shares | |
| 01 Sep 26 | Holding | Holding(s) in Company | |
| 01 Sep 26 | Routine | Transaction in Own Shares | |
| 01 Sep 26 | Routine | Total Voting Rights | |
| 24 Aug 26 | Routine | Transaction in Own Shares | |
| 17 Aug 26 | Routine | Transaction in Own Shares | |
| 10 Aug 26 | Routine | Transaction in Own Shares | |
| 03 Aug 26 | Routine | Transaction in Own Shares | |
| 03 Aug 26 | Routine | Total Voting Rights | |
| 30 Jul 26 | Holding | Holding(s) in Company | |
| 30 Jul 26 | Trading update | Q1 FY27 Trading Statement
Q1 FY27 revenue up 3.9% to £614m with Retail Turnaround Plan delivering market share gains. |
+2.4% |
| 27 Jul 26 | Routine | Transaction in Own Shares | |
| 22 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 20 Jul 26 | Routine | Transaction in Own Shares | |
| 13 Jul 26 | Routine | Transaction in Own Shares | |
| 09 Jul 26 | Routine | Result of AGM | |
| 06 Jul 26 | Routine | Transaction in Own Shares | |
| 29 Jun 26 | Routine | Transaction in Own Shares | |
| 29 Jun 26 | Results | Annual Report
Pets at Home Group Plc: Publication of Annual Report & Accounts in accordance with DTR 4.1 |
−1.2% |
| 24 Jun 26 | Commencement of Share Buy-Back Programme
Pets at Home commences £50 million share buyback programme in two tranches. |
+3.8% | |
| 09 Jun 26 | Results | Annual Report
Pets at Home Group Plc: Posting of Annual Report & Accounts and Notice of AGM |
+0.6% |
| 27 May 26 | Results | FY26 Preliminary Results
Revenue flat, profit down 28% in FY26; Vets grew 5% but Retail fell 1%; new CEO appointed. |
+6.5% |
| 08 Apr 26 | Routine | Total Voting Rights | |
| 31 Mar 26 | Trading update | FY26 pre-close statement
FY26 underlying PBT of c£92m in line with guidance; Retail Turnaround Plan progressing with positive LFL sales growth. |
+1.6% |
| 30 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 03 Mar 26 | Routine | Total Voting Rights | |
| 27 Feb 26 | Routine | Transaction in Own Shares | |
| 26 Feb 26 | Routine | Transaction in Own Shares | |
| 25 Feb 26 | Routine | Transaction in Own Shares | |
| 24 Feb 26 | Routine | Transaction in Own Shares | |
| 23 Feb 26 | Routine | Transaction in Own Shares | |
| 20 Feb 26 | Routine | Transaction in Own Shares | |
| 19 Feb 26 | Routine | Transaction in Own Shares | |
| 18 Feb 26 | Routine | Transaction in Own Shares | |
| 17 Feb 26 | Routine | Transaction in Own Shares | |
| 16 Feb 26 | Routine | Transaction in Own Shares | |
| 13 Feb 26 | Routine | Transaction in Own Shares | |
| 12 Feb 26 | Routine | Transaction in Own Shares | |
| 11 Feb 26 | Routine | Transaction in Own Shares | |
| 10 Feb 26 | Routine | Transaction in Own Shares | |
| 09 Feb 26 | Routine | Transaction in Own Shares | |
| 06 Feb 26 | Routine | Transaction in Own Shares | |
| 05 Feb 26 | Routine | Transaction in Own Shares | |
| 04 Feb 26 | Routine | Transaction in Own Shares | |
| 03 Feb 26 | Routine | Transaction in Own Shares | |
| 02 Feb 26 | Routine | Transaction in Own Shares | |
| 02 Feb 26 | Routine | Total Voting Rights | |
| 30 Jan 26 | Routine | Transaction in Own Shares | |
| 29 Jan 26 | Routine | Transaction in Own Shares | |
| 28 Jan 26 | Trading update | Q3 FY26 Trading Statement
Q3 revenue flat, Vet business up 5%, Retail down 1%, FY26 PBT expected in line with consensus. |
+5.4% |
| 28 Jan 26 | Routine | Transaction in Own Shares | |
| 27 Jan 26 | Routine | Transaction in Own Shares | |
| 26 Jan 26 | Routine | Transaction in Own Shares | |
| 23 Jan 26 | Confirmation of Board Changes
Sarah Pollard appointed CFO Designate from 23 March 2026, succeeding Mike Iddon. |
+2.0% | |
| 23 Jan 26 | Routine | Transaction in Own Shares | |
| 22 Jan 26 | Routine | Transaction in Own Shares | |
| 21 Jan 26 | Routine | Transaction in Own Shares | |
| 20 Jan 26 | Routine | Transaction in Own Shares | |
| 19 Jan 26 | Routine | Transaction in Own Shares | |
| 16 Jan 26 | Routine | Transaction in Own Shares | |
| 15 Jan 26 | Routine | Transaction in Own Shares | |
| 14 Jan 26 | Routine | Transaction in Own Shares | |
| 13 Jan 26 | Routine | Transaction in Own Shares | |
| 12 Jan 26 | Routine | Transaction in Own Shares | |
| 09 Jan 26 | Routine | Transaction in Own Shares | |
| 08 Jan 26 | Routine | Transaction in Own Shares | |
| 07 Jan 26 | Routine | Transaction in Own Shares | |
| 06 Jan 26 | Routine | Transaction in Own Shares | |
| 02 Jan 26 | Routine | Total Voting Rights | |
| 23 Dec 25 | Board change | Appointment of CEO
James Bailey appointed Chief Executive Officer effective 30 March 2026; Ian Burke becomes Non-Executive Chair. |
−0.1% |
| 18 Dec 25 | Routine | Transaction in Own Shares | |
| 17 Dec 25 | Routine | Transaction in Own Shares | |
| 16 Dec 25 | Routine | Transaction in Own Shares | |
| 15 Dec 25 | Routine | Transaction in Own Shares | |
| 12 Dec 25 | Routine | Transaction in Own Shares | |
| 11 Dec 25 | Routine | Transaction in Own Shares | |
| 10 Dec 25 | Routine | Transaction in Own Shares | |
| 09 Dec 25 | Routine | Transaction in Own Shares | |
| 08 Dec 25 | Routine | Transaction in Own Shares | |
| 05 Dec 25 | Routine | Transaction in Own Shares | |
| 04 Dec 25 | Routine | Transaction in Own Shares | |
| 03 Dec 25 | Routine | Transaction in Own Shares | |
| 02 Dec 25 | Routine | Transaction in Own Shares | |
| 01 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 01 Dec 25 | Routine | Total Voting Rights | |
| 01 Dec 25 | Routine | Transaction in Own Shares | |
| 28 Nov 25 | Routine | Transaction in Own Shares | |
| 27 Nov 25 | Routine | Transaction in Own Shares | |
| 26 Nov 25 | Results | FY26 Interim Results
Interim results show retail revenue down 2.3% and profit down 84%, vet business up 8.3%, FY26 guidance unchanged. |
+4.8% |
| 26 Nov 25 | Routine | Transaction in Own Shares | |
| 25 Nov 25 | Routine | Transaction in Own Shares | |
| 24 Nov 25 | Routine | Transaction in Own Shares | |
| 21 Nov 25 | Routine | Transaction in Own Shares | |
| 20 Nov 25 | Routine | Transaction in Own Shares | |
| 19 Nov 25 | Routine | Transaction in Own Shares | |
| 18 Nov 25 | Routine | Transaction in Own Shares | |
| 17 Nov 25 | Routine | Transaction in Own Shares | |
| 14 Nov 25 | Routine | Transaction in Own Shares | |
| 13 Nov 25 | Routine | Transaction in Own Shares | |
| 12 Nov 25 | Routine | Transaction in Own Shares | |
| 11 Nov 25 | Routine | Transaction in Own Shares | |
| 10 Nov 25 | Routine | Transaction in Own Shares | |
| 07 Nov 25 | Routine | Transaction in Own Shares | |
| 06 Nov 25 | Routine | Transaction in Own Shares | |
| 05 Nov 25 | Routine | Transaction in Own Shares | |
| 04 Nov 25 | Routine | Transaction in Own Shares | |
| 03 Nov 25 | Routine | Transaction in Own Shares* | |
| 03 Nov 25 | Routine | Total Voting Rights | |
| 31 Oct 25 | Routine | Transaction in Own Shares | |
| 30 Oct 25 | Change in Director's details
Roger Burnley appointed Non-Executive Director at Marks and Spencer from 1 December 2025. |
−0.9% | |
| 30 Oct 25 | Routine | Transaction in Own Shares | |
| 29 Oct 25 | Routine | Transaction in Own Shares | |
| 28 Oct 25 | Routine | Transaction in Own Shares | |
| 27 Oct 25 | Routine | Transaction in Own Shares | |
| 24 Oct 25 | Routine | Transaction in Own Shares | |
| 23 Oct 25 | Routine | Transaction in Own Shares | |
| 22 Oct 25 | Routine | Transaction in Own Shares | |
| 21 Oct 25 | Routine | Transaction in Own Shares | |
| 20 Oct 25 | Routine | Transaction in Own Shares | |
| 17 Oct 25 | Routine | Transaction in Own Shares | |
| 16 Oct 25 | Holding | Holding(s) in Company | |
| 15 Oct 25 | Routine | Transaction in Own Shares | |
| 14 Oct 25 | Routine | Transaction in Own Shares | |
| 13 Oct 25 | Second Tranche of Share Buy-Back Programme
Second tranche of £12.5m share buyback programme commences, to be completed by March 2026. |
+2.5% | |
| 10 Oct 25 | Director dealing | Director/PDMR Shareholding |
Company filings. Not investment advice.